- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04011566
Assessment of ShuntCheck Performance Characteristics in Asymptomatic Patients With Normal Pressure Hydrocephalus
September 27, 2022 updated by: Naomi Abel, University of South Florida
The purpose of the study is to determine if the ShuntCheck test can correctly identify flow or no flow in a ventriculoperitoneal shunt in patients with asymptomatic normal pressure hydrocephalus.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Naomi Abel, MD
- Phone Number: 813 259-0904
- Email: nabel@usf.edu
Study Contact Backup
- Name: Rachel Karlnoski, MD
- Phone Number: 813 974 8558
- Email: Karlnosk@usf.edu
Study Locations
-
-
Florida
-
Tampa, Florida, United States, 33606
- Recruiting
- University of South Florida Department of Neurological Surgery and Brain Repair
-
Principal Investigator:
- Naomi Abel, MD
-
Contact:
- Naomi Abel, MD
- Phone Number: 813-259-0904
- Email: nabel@health.usf.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
The study population will consist of asymptomatic normal pressure hydrocephalus research subjects who have a ventriculoperitoneal shunt with a single ventricular catheter implanted for adult hydrocephalus and are visiting for routine care.
Evaluation will be within 2 weeks of shunt placement.
Description
Inclusion Criteria:
- Asymptomatic men or women 40 years old or older and have a ventriculoperitoneal shunt placed for normal pressure hydrocephalus and are visiting for routine care.
- Capable of providing valid signed informed consent, or has a legal guardian, health care agent, or surrogate decision maker capable of providing valid, signed informed consent.
Exclusion Criteria:
- Presence of multiple shunts, or presence of more than one distal shunt catheter (regardless of function) crossing the clavicle ipsilateral to the shunt with suspected obstruction;
- ShuntCheck test would interfere with standard patient care, or emergency shunt surgery that cannot be delayed is indicated;
- Presence of an interfering open wound or edema over any portion of the ventriculoperitoneal shunt.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
ShuntCheck
Participants will be administered the ShuntCheck diagnostic test.
|
The intervention is an FDA-cleared device utilizing a transcutaneous thermal convection to analyze shunt flow.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Specificity of ShuntCheck test
Time Frame: 15 minutes
|
15 minutes
|
Negative Predictive Value of ShuntCheck test
Time Frame: 15 minutes
|
15 minutes
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Specificity of performing ShuntCheck test twice
Time Frame: 60 minutes
|
60 minutes
|
Negative Predictive Value of performing ShuntCheck test twice
Time Frame: 60 minutes
|
60 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Naomi Abel, MD, University of South Florida
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 11, 2019
Primary Completion (Anticipated)
June 1, 2024
Study Completion (Anticipated)
January 1, 2025
Study Registration Dates
First Submitted
June 18, 2019
First Submitted That Met QC Criteria
July 3, 2019
First Posted (Actual)
July 8, 2019
Study Record Updates
Last Update Posted (Actual)
September 30, 2022
Last Update Submitted That Met QC Criteria
September 27, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00040697
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
individual participant data that underlies the results reported after deidentification and statistical analysis will be shared following publication for 5 years with researchers who provide a methodologically sound proposal
IPD Sharing Time Frame
individual participant data that underlies the results reported after deidentification and statistical analysis will be shared following publication for 5 years with researchers who provide a methodologically sound proposal
IPD Sharing Access Criteria
data use agreement required and methodologically sound proposal
IPD Sharing Supporting Information Type
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hydrocephalus, Normal Pressure
-
Umeå UniversityCompletedIdiopathic Normal Pressure Hydrocephalus
-
Uppsala University HospitalUppsala University; Swedish Society for Medical ResearchRecruitingIdiopathic Normal Pressure Hydrocephalus (INPH)Sweden
-
Johns Hopkins UniversityUniversity of Utah; Integra LifeSciences CorporationCompletedIdiopathic Normal Pressure Hydrocephalus (INPH)United States, Canada, Sweden
-
Mayo ClinicTerminatedNormal Pressure Hydrocephalus PatientsUnited States
-
Umeå UniversityCompleted
-
Dokuz Eylul UniversityRecruitingNPH (Normal Pressure Hydrocephalus)Turkey
-
University of ZurichRecruitingIdiopathic Normal Pressure HydrocephalusSwitzerland
-
Second Affiliated Hospital, School of Medicine,...Westlake UniversityUnknownIdiopathic Normal Pressure HydrocephalusChina
-
Translational Research Center for Medical Innovation...Johnson & Johnson; Codman & Shurtleff; Eisai Limited; Nihon Medi-Physics Co., Ltd. and other collaboratorsCompletedIdiopathic Normal Pressure HydrocephalusJapan
-
Johns Hopkins UniversityNational Institute of Neurological Disorders and Stroke (NINDS)RecruitingIdiopathic Normal Pressure Hydrocephalus (INPH)United States, Canada, Sweden
Clinical Trials on ShuntCheck
-
NeuroDx DevelopmentNational Institute of Neurological Disorders and Stroke (NINDS); Sinai Hospital...CompletedHydrocephalusUnited States
-
NeuroDx DevelopmentNational Institute of Neurological Disorders and Stroke (NINDS)Unknown
-
University of South FloridaNeuroDx DevelopmentRecruitingHydrocephalus, Normal PressureUnited States
-
University of South FloridaNeuroDx DevelopmentRecruitingPseudotumor CerebriUnited States
-
NeuroDx DevelopmentBoston Children's HospitalUnknownCSF Flow Through the Shunt of a Hydrocephalus PatientUnited States
-
NeuroDx DevelopmentNational Institute of Neurological Disorders and Stroke (NINDS)UnknownSuspected CSF Shunt ObstructionUnited States